SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Jeff Collins will serve as a judge in the Commercializing Innovation competition at the Wake Forest Business School in Winston-Salem, NC
News | 04. 24. 2008
